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§ Diabetes is a chronic, debilitating illness of an escalating
prevalence worldwide1.
§ The current prevalence of diabetes in Qatar is 15.5%,
which is projected to increase to 29.7% by 20352.
§ Diabetes management is still challenging despite
healthcare advancement, warranting the need for a
comprehensive Collaborative Care Model (CCM)3.
§ CCM assures the integration of knowledge, skills, values,
and attitudes that aid team working within and among
professions, and with patients and their families to
improve health outcomes4.
§ Therefore, we aim to evaluate the impact of CCM on
diabetes-related outcomes at a primary healthcare
setting in Qatar.
I. To characterize the clinical profile including diabetes-
related comorbidities and complications of patients with
DM attending an ambulatory diabetes care clinic at a
primary healthcare center.
II. To evaluate the impact of CCM on glycemic control
[glycated hemoglobin A1c (HbA1c), fasting plasma
glucose (FBG), and random blood glucose (RBG)]
among these patients.
III. To evaluate the impact of the CCM on other disease-
related outcomes comprising lipid profile, BP, and body
mass index (BMI).
§ There were no statistically significant differences at
baseline or at 17 months in the medication regimens and
types of medications
§ The most commonly prescribed medication regimen was
oral monotherapy.
§ More patients in the intervention group received
metformin than the control group at baseline and at 17-
months
§ There is a high heterogeneity among the primary studies 
as a result of the variations in original studies setting, 
number of patients, type of pharmacist’s interventions, 
and outcomes measures
§ Each systematic review stratified the primary studies
differently (based on study setting, disease, outcome, or
not stratified)
§ Study design: Retrospective observational study.
§ Outcome measures: HbA1c, FBG, BMI, blood pressure 
(BP), and lipid profile.
§ Statistical analysis: Descriptive and inferential statistics.
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• CCM provision improved HbA1c, RBG, LDL-C, TC,
weight, and BMI significantly in patients with diabetes
within 17 month in a primary healthcare setting.
• Future studies should determine the long-term impact of
CCM in this setting.
• The findings highlight the positive impact of the
integration of different healthcare professionals into the
healthcare team in primary care settings on tangible
health outcomes.
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Figure 5. Medication regimens before and after CCM
Figure 3. Lipid profile parameters
Figure 1. Glycemic control parameters









Diet only Control (n=86)
Intervention (n=168)



















Figure 2. Final mean HbA1c distribution at 17 months
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